QXO, Inc.
QXO
$11.31
-6.61%
QXO, Inc. is a North American distributor of building products operating in the roughly $800 billion building products distribution industry, serving contractors and builders across roofing, insulation, and related categories. The company is positioning itself as a tech-enabled consolidator, explicitly targeting nearly $50 billion in annual revenue within a decade through accretive acquisitions and organic growth, a strategy that distinguishes it from traditional regional distributors. The dominant investor narrative centers on the transformative $17 billion acquisition of TopBuild, announced in April 2026, which dramatically expands QXO's scale and diversification but has raised concerns about dilution, integration risk, and near-term profitability pressure. This deal-driven growth story, combined with a steep share price decline and a deeply negative earnings profile, has made QXO one of the more debated names in the industrial distribution space, with bulls betting on long-term consolidation economics and bears focused on execution and balance sheet risk.…
QXO
QXO, Inc.
$11.31
Related headlines
Investment Opinion: Should I buy QXO Today?
We assign a Hold rating on QXO. The analyst consensus is strong buy with an average target of $28.94, implying 140% upside, but the company's current fundamentals—negative net income, negative free cash flow, and a severe downtrend—warrant caution. The core thesis is that QXO's transformative acquisitions could create a scaled industry leader, but execution risks and near-term profitability challenges are substantial.
Supporting evidence includes: 1) Revenue growth of 70.27% YoY to $3.246 billion in Q2 2026, 2) Gross margin expansion to 24.74% from 14.17% in Q1 2026, 3) A low PS ratio of 1.73x compared to historical levels, and 4) Strong liquidity with $2.774 billion in cash and a current ratio of 3.58. However, the forward PE of 18.82x relies on achieving EPS of $2.11, which is far from the trailing EPS of -$0.024. The stock's beta of 2.291 and 58.37% max drawdown highlight the high risk.
The biggest risks are integration failure of TopBuild, continued cash burn, and dilution. The rating would upgrade to Buy if QXO demonstrates positive free cash flow and net income for two consecutive quarters, or if the stock breaks above resistance at $15 with volume. It would downgrade to Sell if free cash flow remains negative and the stock breaks below $11.14. Relative to its history, QXO is cheap on asset-based metrics (P/B of 1.22x) but expensive on cash flow (P/CF of 45.24x), suggesting a fair valuation at best until profitability is proven.
Sign up to view all
QXO 12-Month Price Forecast
QXO presents a high-risk, high-reward scenario. The bull case hinges on successful integration and profitability, while the bear case focuses on execution risks and cash burn. The analyst consensus is overwhelmingly positive, but the market's skepticism is evident in the stock's 39% decline over the past year. We would upgrade to bullish if QXO reports positive free cash flow and net income for two consecutive quarters, and downgrade to bearish if it breaks below $11.14 with deteriorating fundamentals.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on QXO, Inc.'s 12-month outlook, with a consensus price target around $28.32 and implied upside of +150.4% versus the current price.
Average Target
$28.32
0 analysts
Implied Upside
+150.4%
vs. current price
Analyst Count
—
covering this stock
Price Range
$17 - $50
Analyst target range
Coverage of QXO is robust, with 18 analysts contributing to a consensus recommendation of "strong_buy" and a recommendation mean of 1.22 (where 1.0 is a strong buy). The average target price of $28.94 implies substantial upside of approximately 140% from the current price of $12.06, a spread that is unusually wide and reflects the market's deep disagreement about the company's trajectory. The consensus is overwhelmingly bullish in rating terms, but the magnitude of the implied upside suggests analysts are valuing the company on forward earnings power — anchored by estimated EPS of $2.11 and estimated revenue of $33.1 billion — rather than current fundamentals, which remain loss-making.
The target range spans from a low of $18.00 to a high of $50.00, a 178% spread that signals exceptionally high uncertainty. The high target of $50.00 implies roughly 315% upside and likely assumes successful TopBuild integration, significant multiple expansion, and the realization of the $50 billion revenue ambition, while the low target of $18.00 still implies 49% upside and probably prices in a slower integration with continued margin pressure but no catastrophic outcome. Institutional ratings show a consistent pattern of reaffirmations rather than upgrades or downgrades — Citigroup, RBC Capital, KeyBanc, Stephens, Baird, and Oppenheimer have all maintained bullish ratings (Buy, Outperform, or Overweight) through 2026, with no downgrades in the provided data. This uniformity of positive ratings against a stock down nearly 40% over the past year suggests analysts are looking through near-term pain to a multi-year consolidation thesis, but the wide target dispersion and the stock's persistent underperformance indicate that the market is not yet convinced the strategy will deliver.
Bulls vs Bears: QXO Investment Factors
The bear case currently has stronger evidence, driven by persistent losses, negative free cash flow, and a stock price in a severe downtrend. However, the bull case rests on a credible long-term consolidation thesis, with analysts overwhelmingly bullish and a forward PE of 18.8x implying a profitability inflection. The most critical tension is whether QXO can successfully integrate TopBuild and achieve the estimated EPS of $2.11; failure to do so would likely validate the bear thesis and push the stock below its 52-week low of $11.14. Conversely, any sign of margin expansion and positive cash flow could trigger a sharp re-rating given the 140% analyst upside and high short interest (short ratio 7.59).
Bullish
- Analyst consensus strong buy with 140% upside: 18 analysts rate QXO a strong buy (mean 1.22) with an average target of $28.94, implying 140% upside from $12.06. Even the lowest target of $18.00 implies 49% upside, suggesting the sell-off has overshot fundamentals.
- Revenue growth of 70% YoY: Q2 2026 revenue of $3.246 billion grew 70.27% year-over-year from $1.906 billion, driven by acquisitions. This scale positions QXO as a major consolidator in the $800 billion building products distribution industry.
- Gross margin expansion to 24.74%: Gross margin improved to 24.74% in Q2 2026 from 14.17% in Q1 2026 and 16.94% in Q4 2025, demonstrating early synergy realization and pricing power. This 1,057 basis point sequential expansion supports the bull case for operating leverage.
- Strong liquidity with $2.77B cash: The company holds $2.774 billion in cash with a current ratio of 3.58 and debt-to-equity of only 0.40, providing ample runway to fund integration and future acquisitions without near-term solvency risk.
Bearish
- Persistent net losses and negative FCF: Q2 2026 net income was -$55 million with a net margin of -1.69%, and free cash flow turned negative at -$248.1 million. The trailing net margin of -4.08% and negative FCF per share of -$0.32 indicate the company is not yet self-funding.
- Extreme volatility with beta of 2.29: QXO's beta of 2.291 means it is 129% more volatile than the S&P 500, amplifying downside during market stress. This high beta, combined with a 58.37% max drawdown, makes the stock unsuitable for risk-averse investors.
- Severe relative underperformance: The stock is down 39.43% over one year and 38.84% YTD, versus S&P 500 gains of 15.01% and 12.86%, resulting in -54.44% relative strength over 12 months. This persistent underperformance reflects deep skepticism about the acquisition strategy.
- Integration and dilution risks from TopBuild: The $17 billion TopBuild acquisition, funded partly by $2.038 billion in stock issuance in Q2 2026, has diluted shareholders and created significant integration risk. The deal's success is unproven, and any misstep could further erode investor confidence.
QXO Technical Analysis
QXO is in a sustained and severe downtrend, with the stock down 39.43% over the past year and 38.84% year-to-date, a period during which the S&P 500 gained 15.01% and 12.86% respectively, producing a staggering -54.44% relative strength over 12 months. At a current price of $12.06, the stock sits just 3.3% above its 52-week low of $11.14 and 56.3% below its 52-week high of $27.61, placing it at roughly 5.5% of its 52-week range — a positioning that signals capitulation-like weakness rather than a value opportunity, given the absence of any sustained base-building. The maximum drawdown of -58.37% underscores the severity of the de-rating, and with the stock hugging the lower bound of its range, the burden of proof is squarely on the bulls to demonstrate a trend reversal.
Short-term momentum remains decisively negative and is diverging from an already weak longer-term trend. The 1-month change of -8.77% and 3-month change of -25.60% show that selling pressure has actually accelerated in recent months, with the 3-month decline outpacing the 6-month decline of -36.63% on an annualized basis, indicating persistent distribution rather than stabilization. Relative strength versus the S&P 500 is negative across every measured window — -9.36% over 1 month, -28.94% over 3 months, and -51.70% YTD — confirming that QXO is not merely participating in a broad market pullback but is being actively sold on company-specific concerns. The short ratio of 7.59 days suggests elevated short interest that could fuel sharp squeezes on any positive catalyst, but it also reflects entrenched bearish conviction.
Key technical levels are well-defined: support rests at the 52-week low of $11.14, roughly 7.6% below the current price, while resistance is anchored at the 52-week high of $27.61, a daunting 128.9% above current levels. A breakdown below $11.14 would likely trigger momentum-driven selling and open the door to new all-time lows, whereas a breakout above even intermediate resistance would require a fundamental catalyst, most plausibly clarity on TopBuild integration or a return to profitability. The beta of 2.291 is the critical risk-management consideration — QXO is roughly 129% more volatile than the S&P 500, meaning a 1% market move implies a ~2.3% move in QXO, which demands materially smaller position sizes and wider stop-losses than a typical industrial holding.
Beta
2.28
2.28x market volatility
Max Drawdown
-58.4%
Largest decline past year
52-Week Range
$11-$28
Price range past year
Annual Return
-42.0%
Cumulative gain past year
| Period | QXO Return | S&P 500 |
|---|---|---|
| 1m | -15.3% | +0.9% |
| 3m | -22.4% | +3.4% |
| 6m | -48.4% | +14.4% |
| 1y | -42.0% | +16.2% |
| ytd | -42.6% | +14.0% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
QXO Fundamental Analysis
QXO's revenue trajectory has been transformed by acquisition activity, with Q2 2026 revenue of $3.246 billion representing 70.27% year-over-year growth versus the prior-year quarter's $1.906 billion. However, the multi-quarter progression reveals the lumpy, deal-driven nature of this growth: revenue jumped from just $13.5 million in Q1 2025 to $1.906 billion in Q2 2025, $2.728 billion in Q3 2025, $2.194 billion in Q4 2025, $1.730 billion in Q1 2026, and $3.246 billion in Q2 2026, reflecting the consolidation of large acquisitions rather than consistent organic expansion. The sequential decline from Q3 2025 to Q1 2026, followed by the sharp Q2 2026 rebound, highlights that reported growth is heavily dependent on deal timing and integration, making the underlying organic growth rate difficult to isolate and the investment case contingent on management's ability to sustain momentum post-TopBuild.
Profitability remains elusive despite improving gross margins. Q2 2026 gross margin of 24.74% expanded meaningfully from 14.17% in Q1 2026 and 16.94% in Q4 2025, and gross profit of $803 million on $3.246 billion in revenue shows the scale benefits of the acquisition strategy. Yet net income was -$55 million in Q2 2026, an improvement from -$227.1 million in Q1 2026 and -$90.2 million in Q4 2025, with the net margin of -1.69% in Q2 2026 far better than the -13.13% in Q1 2026 but still negative. Operating income of -$42 million and an operating margin of -1.29% indicate that SG&A of $649 million and interest expense of $38 million continue to overwhelm gross profits, and the trailing net margin of -4.08% confirms the company has not yet achieved the operating leverage needed to convert its revenue scale into bottom-line profitability.
Balance sheet and cash flow metrics present a mixed picture. The debt-to-equity ratio of 0.40 and current ratio of 3.58 suggest reasonable leverage and strong short-term liquidity, supported by $2.774 billion in cash at the end of Q2 2026. However, free cash flow turned negative at -$248.1 million in Q2 2026, a sharp reversal from +$48.1 million in Q1 2026 and +$158.2 million in Q4 2025, driven by a -$417.5 million change in working capital and $1.965 billion in acquisition spending. The TTM free cash flow of $140.6 million against a market cap of $11.8 billion yields a thin FCF yield of roughly 1.2%, and with ROE at -2.88% and ROA at -0.28%, the company is currently destroying rather than creating shareholder value, making it dependent on capital markets — evidenced by $2.038 billion in common stock issued in Q2 2026 — to fund its consolidation ambitions.
Quarterly Revenue
$3.2B
2026-06
Revenue YoY Growth
+70.3%
YoY Comparison
Gross Margin
24.7%
Latest Quarter
Free Cash Flow
$140599999.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is QXO Overvalued?
Because QXO's trailing net income is negative (-$55 million in Q2 2026, with a trailing PE of -30.62x), the PE ratio is not meaningful for valuation; the appropriate primary metric is the price-to-sales ratio, which stands at 1.73x on a trailing basis. The forward PE of 18.82x is the more informative figure, as it implies the market expects a dramatic swing to profitability, with consensus estimated EPS of $2.11 for the forward period against a trailing EPS of -$0.024. The enormous gap between the negative trailing PE and the positive forward PE of 18.82x signals that the market is pricing in a successful integration of TopBuild and a rapid normalization of earnings, a bet that carries substantial execution risk given the current -4.08% net margin.
On a peer-comparison basis, QXO's PS ratio of 1.73x and EV/Sales of 2.00x appear modest for an industrial distributor, but the EV/EBITDA of 51.55x is extraordinarily elevated and reflects the company's currently depressed EBITDA base of $151 million against an enterprise value inflated by acquisition debt and equity issuance. The price-to-book ratio of 1.22x is low in absolute terms, suggesting the market values the company near its accounting net asset value, which could indicate either a value opportunity or skepticism about the carrying value of acquired assets. Without a reliable industry-average PS or EV/EBITDA benchmark in the provided data, the most defensible conclusion is that QXO trades at a premium on cash-flow-based metrics (P/CF of 45.24x) and a discount on asset-based metrics (P/B of 1.22x), a divergence typical of a company in the midst of a transformative but unproven consolidation.
Historical context is complicated by QXO's radical transformation from a small legacy business into a large-scale distributor. The PS ratio has compressed dramatically from 452.50x in Q1 2025 and 8.36x in Q1 2026 to the current 1.73x, reflecting the massive revenue base added through acquisitions rather than a deterioration in market sentiment alone. Similarly, the P/B ratio has fallen from over 800x in 2023 to 1.22x today, as the balance sheet absorbed billions in acquired assets and issued equity. This compression suggests the stock is near the bottom of its own historical valuation band on asset-based measures, but the negative FCF per share of -$0.32 and the -53.44x price-to-free-cash-flow ratio indicate that cash-flow-based valuation remains deeply unfavorable, leaving the stock in a "cheap on assets, expensive on cash flow" posture that will only resolve through demonstrated earnings delivery.
PE
-30.6x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 13x~122x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
51.6x
Enterprise Value Multiple
Investment Risk Disclosure
QXO faces significant financial and operational risks. The company reported a net loss of $55 million in Q2 2026, with a net margin of -1.69%, and free cash flow turned negative at -$248.1 million due to a -$417.5 million working capital swing and $1.965 billion in acquisition spending. Although debt-to-equity is moderate at 0.40 and cash stands at $2.774 billion, the company's reliance on capital markets is evident from $2.038 billion in stock issuance in Q2 2026. The integration of TopBuild, a $17 billion acquisition, poses substantial execution risk, and any delays or cost overruns could further pressure margins and liquidity.
Market and competitive risks are amplified by QXO's high beta of 2.291, making it highly sensitive to market downturns. The stock has underperformed the S&P 500 by 54.44% over the past year, and its 52-week range positioning at just 5.5% of the range signals capitulation-like weakness. The building products distribution industry is highly competitive, and QXO's tech-enabled consolidation strategy may face challenges from entrenched regional players. Additionally, the recent news highlights integration risks and suggests competitor IBP may be a safer alternative, indicating that QXO's premium valuation on cash-flow metrics (EV/EBITDA of 51.55x) could compress if growth disappoints.
The worst-case scenario involves a failed integration of TopBuild, leading to sustained negative free cash flow, further dilution, and a breakdown below the 52-week low of $11.14. In this scenario, the stock could decline to the analyst low target of $18.00? No, that's above current price. Actually, the 52-week low is $11.14, which is 7.6% below the current price of $12.06. A more severe scenario could see the stock drop to single digits, implying a potential loss of 20-30% from current levels. Given the max drawdown of 58.37%, investors could face significant losses if the bear case materializes.
FAQ
The key risks include: 1) Integration risk from the $17 billion TopBuild acquisition, which could lead to cost overruns and synergy shortfalls; 2) Financial risk, with negative free cash flow of -$248.1 million in Q2 2026 and a net loss of $55 million; 3) Market risk, given the high beta of 2.291, which amplifies downturns; and 4) Dilution risk, as the company issued $2.038 billion in stock in Q2 2026 to fund acquisitions. These risks are ranked from most to least severe, with integration and financial risks being the most immediate.
Our 12-month forecast has three scenarios: bull case (25% probability) targeting $28-$50, base case (50% probability) targeting $15-$22, and bear case (25% probability) targeting $8-$11.14. The base case assumes gradual integration progress and revenue growth to $33.1 billion, with the stock trading in a range. The bull case requires successful integration and positive free cash flow, while the bear case involves integration failures and continued cash burn. The most likely scenario is the base case, with a target around $18, implying 49% upside from current levels.
QXO's valuation is mixed. On a price-to-sales basis, it trades at 1.73x, which is low for a distributor, but on EV/EBITDA it is extremely high at 51.55x due to depressed EBITDA. The forward PE of 18.82x suggests the market expects a sharp earnings recovery. Compared to its own history, the PS ratio has compressed from over 400x to 1.73x, indicating the stock is cheap on revenue but expensive on cash flow. The market is pricing in a successful integration and profitability inflection, leaving little room for error.
QXO is a high-risk, high-reward stock that may be suitable for aggressive investors. The analyst consensus is strong buy with a target of $28.94, implying 140% upside, but the company is currently unprofitable with negative free cash flow. The stock is down 39% over the past year and trades near its 52-week low, reflecting deep skepticism. A good buy case rests on successful integration of TopBuild and a path to profitability, which is not guaranteed. Investors should consider position sizing carefully due to the beta of 2.291.
QXO is more suitable for long-term investment, given its multi-year consolidation strategy and current unprofitability. Short-term trading is highly risky due to the beta of 2.291 and high volatility. The company does not pay a meaningful dividend (yield 0.89%), so returns depend on capital appreciation. Earnings visibility is low, with the next catalyst likely the Q3 2026 earnings report. A minimum holding period of 2-3 years is recommended to allow the integration to play out and profitability to emerge.